BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer. 2011;14:97-100. [PMID: 21573921 DOI: 10.1007/s10120-011-0040-6] [Cited by in Crossref: 189] [Cited by in F6Publishing: 153] [Article Influence: 18.9] [Reference Citation Analysis]
Number Citing Articles
1 Cao S, Zou T, Sun Q, Liu T, Fan T, Yin Q, Fan X, Jiang J, Raymond D, Wang Y, Zhang B, Lv Y, Zhang X, Ling T, Zhuge Y, Wang L, Zou X, Xu G, Huang Q. Safety and long-term outcomes of early gastric cardiac cancer treated with endoscopic submucosal dissection in 499 Chinese patients. Therap Adv Gastroenterol 2020;13:1756284820966929. [PMID: 33193812 DOI: 10.1177/1756284820966929] [Reference Citation Analysis]
2 Lee SH, Choi CW, Kim SJ, Choi CI, Kim DH, Jeon TY, Kim DH, Lee HJ, Kim KH, Hwang SH. Risk factors for lymph node metastasis in mucosal gastric cancer and re-evaluation of endoscopic submucosal dissection. Ann Surg Treat Res 2016;91:118-26. [PMID: 27617252 DOI: 10.4174/astr.2016.91.3.118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Haraikawa M, Kudo H, Shibuya T, Kogure Y, Takase M, Inage H, Yokota T, Htun H, Tagaya E, Fan R, Houshito H, Taniguchi G, Sakamoto K, Nagahara A. Efficacy of CO₂ Infusion for Preoperative Computed Tomographic Angiography with Computed Tomographic Colonography. Med Sci Monit 2021;27:e931055. [PMID: 33993185 DOI: 10.12659/MSM.931055] [Reference Citation Analysis]
4 Fernández-Moreno MC, Martí-Obiol R, López F, Ortega J. Modified Devine Exclusion for Unresectable Distal Gastric Cancer in Symptomatic Patients. Case Rep Gastroenterol 2017;11:9-16. [PMID: 28203132 DOI: 10.1159/000452759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yoshida H, Shimazu T, Kiyuna T, Marugame A, Yamashita Y, Cosatto E, Taniguchi H, Sekine S, Ochiai A. Automated histological classification of whole-slide images of gastric biopsy specimens. Gastric Cancer. 2018;21:249-257. [PMID: 28577229 DOI: 10.1007/s10120-017-0731-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
6 Schmidt B, Yoon SS. D1 versus D2 lymphadenectomy for gastric cancer. J Surg Oncol. 2013;107:259-264. [PMID: 22513454 DOI: 10.1002/jso.23127] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
7 Pan T, Galiullin D, Chen XL, Zhang WH, Yang K, Liu K, Zhao LY, Chen XZ, Hu JK. Incidence of adhesive small bowel obstruction after gastrectomy for gastric cancer and its risk factors: a long-term retrospective cohort study from a high-volume institution in China. Updates Surg 2021;73:615-26. [PMID: 33550510 DOI: 10.1007/s13304-021-00983-y] [Reference Citation Analysis]
8 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
9 Xu BB, Lu J, Zheng ZF, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng CH, Huang CM, Li P. The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data. Gastric Cancer 2019;22:1016-28. [PMID: 30739259 DOI: 10.1007/s10120-019-00936-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
10 So JB, Rao J, Wong AS, Chan YH, Pang NQ, Tay AYL, Yung MY, Su Z, Phua JNS, Shabbir A, Ng EKW. Roux-en-Y or Billroth II Reconstruction After Radical Distal Gastrectomy for Gastric Cancer: A Multicenter Randomized Controlled Trial. Ann Surg. 2018;267:236-242. [PMID: 28383294 DOI: 10.1097/sla.0000000000002229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
11 Garg PK, Jakhetiya A, Sharma J, Ray MD, Pandey D. Lymphadenectomy in gastric cancer: Contentious issues. World J Gastrointest Surg 2016;8:294-300. [PMID: 27152135 DOI: 10.4240/wjgs.v8.i4.294] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
12 Zheng Z, Zhang Y, Zhang L, Li Z, Wu X, Liu Y, Bu Z, Ji J. A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients. BMC Cancer. 2016;16:92. [PMID: 26873736 DOI: 10.1186/s12885-016-2132-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
13 Zhu Z, Gong Y, Xu H. Clinical and pathological staging of gastric cancer: Current perspectives and implications. Eur J Surg Oncol 2020;46:e14-9. [PMID: 32732091 DOI: 10.1016/j.ejso.2020.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Morita S, Fukagawa T, Fujiwara H, Katai H. Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan. World J Gastrointest Oncol. 2016;8:707-714. [PMID: 27672429 DOI: 10.4251/wjgo.v8.i9.707] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
15 Yoshikawa T, Rino Y, Yukawa N, Oshima T, Tsuburaya A, Masuda M. Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy. Surg Today. 2014;44:11-21. [PMID: 23508452 DOI: 10.1007/s00595-013-0529-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
16 Oguri Y, Cho H, Oohinata R, Onoyama H, Takada R, Motoi T. Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: A case report and literature review. Mol Clin Oncol 2018;9:661-5. [PMID: 30546898 DOI: 10.3892/mco.2018.1739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Nakamura K, Kuwata T, Shimoda T, Mizusawa J, Katayama H, Kushima R, Taniguchi H, Sano T, Sasako M, Fukuda H. Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A). Gastric Cancer. 2015;18:597-604. [PMID: 24968818 DOI: 10.1007/s10120-014-0401-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
18 Katsura Y, Okabayashi T, Matsumoto M, Ozaki K, Shibuya Y. A case of stage IV gastric cancer with para-aortic lymph node metastasis showing pathological complete response after neoadjuvant chemotherapy. Surg Case Rep 2020;6:14. [PMID: 31925618 DOI: 10.1186/s40792-020-0788-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hsu JT, Liao CK, Le PH, Chen TH, Lin CJ, Chen JS, Chiang KC, Yeh TS. Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer. Medicine (Baltimore) 2015;94:e1589. [PMID: 26426635 DOI: 10.1097/MD.0000000000001589] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
20 Polanowski P, Wydmański J, Tukiendorf A, Składowski K. The analysis of absorbed dose by pancreas during gastric cancer radiotherapy. Radiother Oncol 2020;151:20-3. [PMID: 32679311 DOI: 10.1016/j.radonc.2020.07.009] [Reference Citation Analysis]
21 Hur H, Paik MJ, Xuan Y, Nguyen DT, Ham IH, Yun J, Cho YK, Lee G, Han SU. Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer. PLoS One. 2014;9:e98581. [PMID: 24911788 DOI: 10.1371/journal.pone.0098581] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
22 Güner A, Hyung WJ. Minimally invasive surgery for gastric cancer. Ulus Cerrahi Derg. 2014;30:1-9. [PMID: 25931879 DOI: 10.5152/ucd.2014.2607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Song XH, Liu K, Sun LF, Chen XL, Zhao LY, Zhang WH, Chen XZ, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Clinicopathological characteristics and prognostic factors of remnant gastric cancer: A single-center retrospective analysis of 90 patients. Int J Surg. 2018;51:97-103. [PMID: 29367041 DOI: 10.1016/j.ijsu.2018.01.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Park JY, Kim SG, Kim J, Han SJ, Oh S, Choi JM, Lim JH, Chung H, Jung HC. Risk factors for early metachronous tumor development after endoscopic resection for early gastric cancer. PLoS One 2017;12:e0185501. [PMID: 28950014 DOI: 10.1371/journal.pone.0185501] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
25 Choi BS, Oh HK, Park SH, Park JM. Comparison of laparoscopy-assisted and totally laparoscopic distal gastrectomy: the short-term outcome at a low volume center. J Gastric Cancer 2013;13:44-50. [PMID: 23610718 DOI: 10.5230/jgc.2013.13.1.44] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
26 Xiong SW, Zhang DY, Liu XM, Liu Z, Zhang FT. Comparison of different gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus. World J Gastroenterol 2014;20:18427-31. [PMID: 25561812 DOI: 10.3748/wjg.v20.i48.18427] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Yoshimizu S, Yamamoto Y, Horiuchi Y, Omae M, Yoshio T, Ishiyama A, Hirasawa T, Tsuchida T, Fujisaki J. Diagnostic performance of routine esophagogastroduodenoscopy using magnifying endoscope with narrow-band imaging for gastric cancer. Dig Endosc 2018;30:71-8. [PMID: 28685858 DOI: 10.1111/den.12916] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Yamamoto M, Takahashi T, Serada S, Sugase T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Naka T, Mori M, Doki Y. Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer. Cancer Sci 2017;108:2052-60. [PMID: 28746773 DOI: 10.1111/cas.13329] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
29 Hundahl SA. Surgery for gastric cancer: what the trials indicate. Surg Oncol Clin N Am 2012;21:79-97. [PMID: 22098833 DOI: 10.1016/j.soc.2011.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Lu J, Xu Y, Wu Y, Huang XY, Xie JW, Wang JB, Lin JX, Li P, Zheng CH, Huang AM, Huang CM. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer. BMC Cancer 2019;19:920. [PMID: 31521128 DOI: 10.1186/s12885-019-6089-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
31 Chen J, Wu L, Zhang Z, Zheng S, Lin Y, Ding N, Sun J, Shi L, Xue M. A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis. Cancer Med 2021;10:944-55. [PMID: 33350173 DOI: 10.1002/cam4.3680] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Wang Y, Ye D, Kang M, Zhu L, Pan S, Wang F. Risk Factors and Patterns of Abdominal Lymph Node Recurrence After Radical Surgery for Locally Advanced Thoracic Esophageal Squamous Cell Cancer. Cancer Manag Res 2020;12:3959-69. [PMID: 32547231 DOI: 10.2147/CMAR.S249810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Bo T, Peiwu Y, Feng Q, Yongliang Z, Yan S, Yingxue H, Huaxing L. Laparoscopy-Assisted vs. Open Total Gastrectomy for Advanced Gastric Cancer: Long-Term Outcomes and Technical Aspects of a Case–Control Study. J Gastrointest Surg 2013;17:1202-8. [DOI: 10.1007/s11605-013-2218-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 7.9] [Reference Citation Analysis]
34 Lee SH, Kim KH, Choi CW, Kim SJ, Kim DH, Choi CI, Hwang SH. Reduction rate of C-reactive protein as an early predictor of postoperative complications and a reliable discharge indicator after gastrectomy for gastric cancer. Ann Surg Treat Res 2019;97:65-73. [PMID: 31384611 DOI: 10.4174/astr.2019.97.2.65] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Wang L, Zhang Y, Chen Y, Tan J, Wang L, Zhang J, Yang C, Ma Q, Ge Y, Xu Z, Pan Z, Du L, Yan F, Yao W, Zhang H. The Performance of a Dual-Energy CT Derived Radiomics Model in Differentiating Serosal Invasion for Advanced Gastric Cancer Patients After Neoadjuvant Chemotherapy: Iodine Map Combined With 120-kV Equivalent Mixed Images. Front Oncol 2020;10:562945. [PMID: 33585186 DOI: 10.3389/fonc.2020.562945] [Reference Citation Analysis]
36 Zhang K, Huang X, Gao Y, Liang W, Xi H, Cui J, Li J, Zhu M, Liu G, Zhao H, Hu C, Liu Y, Qiao Z, Wei B, Chen L. Robot-Assisted Versus Laparoscopy-Assisted Proximal Gastrectomy for Early Gastric Cancer in the Upper Location: Comparison of Oncological Outcomes, Surgical Stress, and Nutritional Status. Cancer Control 2018;25:1073274818765999. [PMID: 29582668 DOI: 10.1177/1073274818765999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Sato Y, Katai H, Ito M, Yura M, Otsuki S, Yamagata Y, Morita S. Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction? J Gastric Cancer 2018;18:339-47. [PMID: 30607297 DOI: 10.5230/jgc.2018.18.e33] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 In H, Ravetch E, Langdon-Embry M, Palis B, Ajani JA, Hofstetter WL, Kelsen DP, Sano T. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging. Gastric Cancer 2018;21:1-9. [PMID: 28948368 DOI: 10.1007/s10120-017-0765-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
39 Seo HS, Song KY, Jung YJ, Park SM, Jeon HM, Kim W, Chin HM, Kim JJ, Kim SK, Chun KH, Kim JG, Lee JH, Lee HH, Kim DJ, Yoo HM, Kim CH, Kim EY, Park CH; Catholic Gastric Cancer Study Group (CGCSG). Radical Gastrectomy After Chemotherapy May Prolong Survival in Stage IV Gastric Cancer: A Korean Multi-institutional Analysis. World J Surg. 2018;42:3286-3293. [PMID: 29717344 DOI: 10.1007/s00268-018-4635-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Kawakami H, Fujitani K, Matsuyama J, Akamaru Y, Tamura S, Endo S, Kimura Y, Makari Y, Tamura T, Sugimoto N, Sakai D, Tsujinaka T, Goto M, Kurokawa Y, Shimokawa T, Satoh T; Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG). Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials. Int J Clin Oncol 2020;25:1635-43. [PMID: 32494981 DOI: 10.1007/s10147-020-01711-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers. Biochem Biophys Res Commun 2020;529:582-9. [PMID: 32736677 DOI: 10.1016/j.bbrc.2020.05.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW. Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol. 2014;21:3008-3014. [PMID: 24700300 DOI: 10.1245/s10434-014-3664-z] [Cited by in Crossref: 121] [Cited by in F6Publishing: 100] [Article Influence: 17.3] [Reference Citation Analysis]
43 Chen QY, Lin GT, Zhong Q, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Huang CM. Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance. Gastric Cancer 2020;23:184-94. [PMID: 31300914 DOI: 10.1007/s10120-019-00986-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
44 Tanaka K, Maekawa S, Yoshida T, Yamaguchi T, Takano S, Matsuda S, Hayakawa H, Ishida Y, Muraoka M, Kawakami S, Fukasawa Y, Kuno T, Iwamoto F, Tsukui Y, Kobayashi S, Asakawa Y, Shindo H, Fukasawa M, Nakayama Y, Inoue T, Uetake T, Ohtaka M, Sato T, Mochizuki K, Enomoto N. Role of magnifying endoscopy with narrow-band imaging in the diagnosis of noninvasive gastric neoplasia. JGH Open 2021;5:446-53. [PMID: 33860094 DOI: 10.1002/jgh3.12513] [Reference Citation Analysis]
45 Shimoda Y, Fujikawa H, Komori K, Watanabe H, Kano K, Yamada T, Shiozawa M, Morinaga S, Katsumata K, Tsuchida A, Ogata T, Oshima T. Preoperative Utility of the Glasgow Prognostic Score on Outcomes of Patients with Locally Advanced Gastric Cancer. J Gastrointest Cancer 2021. [PMID: 33460001 DOI: 10.1007/s12029-021-00584-3] [Reference Citation Analysis]
46 Zhao L, Zhao AG, Zhao G, Xu Y, Zhu XH, Cao ND, Zheng J, Yang JK, Xu JH. Survival benefit of traditional chinese herbal medicine (a herbal formula for invigorating spleen) in gastric cancer patients with peritoneal metastasis. Evid Based Complement Alternat Med 2014;2014:625493. [PMID: 24723961 DOI: 10.1155/2014/625493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
47 Sanford M. Trastuzumab: a review of its use in HER2-positive advanced gastric cancer. Drugs. 2013;73:1605-1615. [PMID: 24057416 DOI: 10.1007/s40265-013-0119-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 Sugimoto A, Nishida T, Osugi N, Takahashi K, Mukai K, Nakamatsu D, Matsubara T, Hayashi S, Yamamoto M, Nakajima S, Fukui K, Inada M. Prediction of survival benefit when deciding between chemotherapy and best supportive therapy in elderly patients with advanced gastric cancer: A retrospective cohort study. Mol Clin Oncol 2019;10:83-91. [PMID: 30655981 DOI: 10.3892/mco.2018.1772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
49 Kim CH, Park SM, Kim JJ. The Impact of Preoperative Low Body Mass Index on Postoperative Complications and Long-term Survival Outcomes in Gastric Cancer Patients. J Gastric Cancer 2018;18:274-86. [PMID: 30276004 DOI: 10.5230/jgc.2018.18.e30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Cui J, Deng J, Ding X, Zhang L, Zhang R, Wu W, Hao X, Liang H. Blood transfusion does not affect survival of gastric cancer patients. J Surg Res 2016;200:98-104. [PMID: 26253454 DOI: 10.1016/j.jss.2015.07.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
51 Lee HH, Lee SH, Song KY, Na SJ, O JH, Park JM, Jung ES, Choi MG, Park CH. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer. BMC Cancer 2017;17:670. [PMID: 28974196 DOI: 10.1186/s12885-017-3668-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
52 Fuster D, Mayoral M, Rubello D, Pineda E, Fernández-Esparrach G, Pagès M, Colletti PM, Pons F. Is there a role for PET/CT with esophagogastric junction adenocarcinoma? Clin Nucl Med. 2015;40:e201-e207. [PMID: 25546207 DOI: 10.1097/RLU.0000000000000661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
53 Kikuchi H, Miyata H, Konno H, Kamiya K, Tomotaki A, Gotoh M, Wakabayashi G, Mori M. Development and external validation of preoperative risk models for operative morbidities after total gastrectomy using a Japanese web-based nationwide registry. Gastric Cancer 2017;20:987-97. [PMID: 28285387 DOI: 10.1007/s10120-017-0706-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
54 Honda M, Hiki N, Nunobe S, Ohashi M, Kumagai K, Hashimoto Y, Mine S, Kamiya S, Sano T, Yamaguchi T. Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial. Journal of the American College of Surgeons 2015;221:273-9. [DOI: 10.1016/j.jamcollsurg.2015.03.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
55 Xiong SW, Cao J, Liu XM, Deng XM, Liu Z, Zhang FT. Effect of Modified Roux-en-Y Gastric Bypass Surgery on GLP-1, GIP in Patients with Type 2 Diabetes Mellitus. Gastroenterol Res Pract 2015;2015:625196. [PMID: 26167177 DOI: 10.1155/2015/625196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
56 Zhang F, Huang X, Song Y, Gao P, Zhou C, Guo Z, Shi J, Wu Z, Wang Z. Conversion Surgery for Stage IV Gastric Cancer. Front Oncol 2019;9:1158. [PMID: 31788445 DOI: 10.3389/fonc.2019.01158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
57 Takahashi M, Hasegawa K, Oba M, Saiura A, Arita J, Sakamoto Y, Shinozaki E, Mizunuma N, Matsuyama Y, Kokudo N. Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases. Invest New Drugs 2016;34:468-73. [PMID: 27155613 DOI: 10.1007/s10637-016-0356-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Ahn SH, Lee JH, Park DJ, Kim HH. Laparoscopy-assisted proximal gastrectomy for early gastric cancer is an ugly duckling with unsolved concerns: oncological safety, late complications, and functional benefit. Gastric Cancer 2013;16:448-50. [PMID: 23483303 DOI: 10.1007/s10120-013-0245-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
59 Tokunaga M, Kondo J, Tanizawa Y, Bando E, Kawamura T, Terashima M. Postoperative intra-abdominal complications assessed by the Clavien-Dindo classification following open and laparoscopy-assisted distal gastrectomy for early gastric cancer. J Gastrointest Surg 2012;16:1854-9. [PMID: 22847575 DOI: 10.1007/s11605-012-1981-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
60 Seo HS, Jung YJ, Kim JH, Park CH, Lee HH. Necessity of D2 lymph node dissection in older patients ≥80years with gastric cancer. J Geriatr Oncol 2018;9:115-9. [PMID: 28988631 DOI: 10.1016/j.jgo.2017.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Ozawa H, Kawakubo H, Takeuchi M, Ishibashi Y, Matsuda S, Mayanagi S, Takemura R, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Prognostic Significance of the Number and Extent of Metastatic Lymph Nodes in Patients with Esophageal Cancer: Comparison of the Union for International Cancer Control 8th Edition and Japan Esophageal Society Japanese Classification of Esophageal Cancer 11th Edition Classifications for Esophageal Cancer. Ann Surg Oncol 2021. [PMID: 33748898 DOI: 10.1245/s10434-020-09545-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Osumi H, Kawachi H, Murai K, Kusafuka K, Inoue S, Kitamura M, Yoshio T, Kakusima N, Ishihara R, Ono H, Yamamoto N, Sugino T, Nakatsuka S, Ida S, Nunobe S, Bando E, Omori T, Takeuchi K, Fujisaki J. Risk stratification for lymph node metastasis using Epstein–Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study. Gastric Cancer 2019;22:1176-82. [DOI: 10.1007/s10120-019-00963-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
63 Talsma AK, Ong CA, Liu X, van Hagen P, Van Lanschot JJ, Tilanus HW, Hardwick RH, Carroll NR, Spaander MC, Fitzgerald RC, Wijnhoven BP. Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival. World J Surg 2014;38:106-13. [PMID: 24101018 DOI: 10.1007/s00268-013-2236-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
64 Yi HW, Kim SM, Kim SH, Shim JH, Choi MG, Lee JH, Noh JH, Sohn TS, Bae JM, Kim S. Complications leading reoperation after gastrectomy in patients with gastric cancer: frequency, type, and potential causes. J Gastric Cancer 2013;13:242-6. [PMID: 24511420 DOI: 10.5230/jgc.2013.13.4.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
65 Kim KH, Lee SH, Choi CW, Kim SJ, Choi CI, Kim DH, Jeon TY, Kim DH, Hwang SH. Effect of extramucin pools in gastric cancer patients. Ann Surg Treat Res 2015;89:254-60. [PMID: 26576405 DOI: 10.4174/astr.2015.89.5.254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Ren J, Niu G, Wang X, Song T, Hu Z, Ke C. Effect of Age on Prognosis of Gastric Signet-Ring Cell Carcinoma: A SEER Database Analysis. Med Sci Monit. 2018;24:8524-8532. [PMID: 30473583 DOI: 10.12659/msm.911766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
67 Li Z, Wu X, Gao X, Shan F, Ying X, Zhang Y, Ji J. Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma. Br J Cancer 2021;124:942-50. [PMID: 33262519 DOI: 10.1038/s41416-020-01190-z] [Reference Citation Analysis]
68 Lin J, Zhang W, Huang Y, Chen W, Wu R, Chen X, Lou N, Wang P. Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study. Cancer Manag Res 2018;10:4935-44. [PMID: 30464594 DOI: 10.2147/CMAR.S175421] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
69 Okubo K, Arigami T, Matsushita D, Kijima T, Shimonosono M, Uenosono Y, Yanagita S, Kurahara H, Mori S, Ohtsuka T, Natsugoe S. Clinical impact of creatine phosphokinase and c-reactive protein as predictors of postgastrectomy complications in patients with gastric cancer. BMC Cancer 2021;21:95. [PMID: 33485312 DOI: 10.1186/s12885-021-07801-z] [Reference Citation Analysis]
70 Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, Shin CM, Yoon H, Jung HC. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer. World J Gastroenterol. 2015;21:571-577. [PMID: 25593477 DOI: 10.3748/wjg.v21.i2.571] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
71 Bali CD, Lianos GD, Roukos DH. Gastric cancer guidelines and genome differences between Japan and the west. Future Oncology 2013;9:1053-6. [DOI: 10.2217/fon.13.78] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
72 Langer R, Becker K. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy. Virchows Arch 2018;472:175-86. [PMID: 28918544 DOI: 10.1007/s00428-017-2232-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
73 Aoyama T, Yoshikawa T, Hayashi T, Kuwabara H, Mikayama Y, Ogata T, Cho H, Tsuburaya A. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy. Ann Surg Oncol. 2012;19:1568-1574. [PMID: 22143578 DOI: 10.1245/s10434-011-2158-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
74 Lu X, Chen F, Liu X, Yuan D, Zi Y, He X, Zhu D. Detection and clinical significance of DNA repair gene ERCC8 tag SNPs in gastric cancer. Turk J Gastroenterol 2018;29:392-6. [PMID: 30249552 DOI: 10.5152/tjg.2018.17662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Yang F, Wang S, Sun S, Liu X, Ge N, Wang G, Guo J, Liu W, Feng L, Ma W. Factors associated with endoscopic full-thickness resection of gastric submucosal tumors. Surg Endosc. 2015;29:3588-3593. [PMID: 25894443 DOI: 10.1007/s00464-015-4113-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
76 Lee YI, Lee SK. Endoscopic Submucosal Dissection of an Inverted Early Gastric Cancer-Forming False Gastric Diverticulum. Clin Endosc 2016;49:86-90. [PMID: 26855930 DOI: 10.5946/ce.2016.49.1.86] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
77 Hii MW, Smithers BM, Gotley DC, Thomas JM, Thomson I, Martin I, Barbour AP. Impact of postoperative morbidity on long-term survival after oesophagectomy. British Journal of Surgery 2013;100:95-104. [DOI: 10.1002/bjs.8973] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
78 Aoyama T, Yoshikawa T, Hayashi T, Kuwabara H, Mikayama Y, Ogata T, Cho H, Tsuburaya A. Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for gastric cancer. Gastric Cancer 2013;16:133-9. [DOI: 10.1007/s10120-012-0158-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
79 Qiu Y, Mao YT, Zhu JH, Zhao K, Wang JF, Huang JM, Chang GQ, Guan YT, Huang FY, Hu YJ, Chen JQ, Liu JL. CLIC1 knockout inhibits invasion and migration of gastric cancer by upregulating AMOT-p130 expression. Clin Transl Oncol 2021;23:514-25. [PMID: 32656583 DOI: 10.1007/s12094-020-02445-0] [Reference Citation Analysis]
80 Takeuchi M, Kawakubo H, Mayanagi S, Suzuki Y, Okabayashi K, Yamashita T, Kamiya S, Irino T, Fukuda K, Nakamura R, Suda K, Wada N, Takeuchi H, Kitagawa Y. Perioperative risk calculator for distal gastrectomy predicts overall survival in patients with gastric cancer. Gastric Cancer 2019;22:624-31. [PMID: 30478691 DOI: 10.1007/s10120-018-0896-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
81 Sakamoto T, Fujiogi M, Matsui H, Fushimi K, Yasunaga H. Short-Term Outcomes of Laparoscopic and Open Total Gastrectomy for Gastric Cancer: A Nationwide Retrospective Cohort Analysis. Ann Surg Oncol 2020;27:518-26. [PMID: 31407172 DOI: 10.1245/s10434-019-07688-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
82 Barchi LC, Jacob CE, Franciss MY, Kappaz GT, Rodrigues Filho ED, Zilberstein B. Robotic digestive tract reconstruction after total gastrectomy for gastric cancer: a simple way to do it: Robotic digestive tract reconstruction after total gastrectomy. Int J Med Robotics Comput Assist Surg 2016;12:598-603. [DOI: 10.1002/rcs.1720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
83 Osumi H, Takahari D, Shinozaki E, Chin K, Ogura M, Wakatsuki T, Ichimura T, Nakayama I, Matsushima T, Yamaguchi K. Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer. Gastric Cancer 2018;21:267-75. [DOI: 10.1007/s10120-017-0729-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
84 Takahashi M, Takeuchi H, Tsuwano S, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Kitagawa Y. Surgical Resection of Remnant Gastric Cancer Following Distal Gastrectomy: A Retrospective Clinicopathological Study. Ann Surg Oncol. 2016;23:511-521. [PMID: 26104543 DOI: 10.1245/s10434-015-4678-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
85 Irino T, Hiki N, Ohashi M, Nunobe S, Tokunaga M, Sano T, Yamaguchi T. Characteristics of gastric stump cancer: A single hospital retrospective analysis of 262 patients. Surgery. 2016;159:1539-1547. [PMID: 26879072 DOI: 10.1016/j.surg.2016.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
86 Cheng J, Wu X, Yang A, Jiang Q, Yao F, Feng Y, Guo T, Zhou W, Wu D, Yan X, Lai Y, Qian J, Lu X, Fang W. Model to identify early-stage gastric cancers with deep invasion of submucosa based on endoscopy and endoscopic ultrasonography findings.Surg Endosc. 2018;32:855-863. [PMID: 28733747 DOI: 10.1007/s00464-017-5754-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
87 Jeon MY, Park JC, Hahn KY, Shin SK, Lee SK, Lee YC. Long-term outcomes after noncurative endoscopic resection of early gastric cancer: the optimal time for additional endoscopic treatment. Gastrointest Endosc. 2018;87:1003-1013.e2. [PMID: 29031882 DOI: 10.1016/j.gie.2017.10.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
88 Zhang K, Shi H, Xi H, Wu X, Cui J, Gao Y, Liang W, Hu C, Liu Y, Li J, Wang N, Wei B, Chen L. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer. Theranostics. 2017;7:213-227. [PMID: 28042329 DOI: 10.7150/thno.16044] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 24.5] [Reference Citation Analysis]
89 Sakurai K, Muguruma K, Nagahara H, Kimura K, Toyokawa T, Amano R, Kubo N, Tanaka H, Ohtani H, Yashiro M, Maeda K, Ohira M, Hirakawa K. The outcome of surgical treatment for elderly patients with gastric carcinoma. J Surg Oncol 2015;111:848-54. [PMID: 25753213 DOI: 10.1002/jso.23896] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
90 Irino T, Hiki N, Nunobe S, Ohashi M, Tanimura S, Sano T, Yamaguchi T. Subtotal gastrectomy with limited lymph node dissection is a feasible treatment option for patients with early gastric stump cancer. J Gastrointest Surg. 2014;18:1429-1433. [PMID: 24944156 DOI: 10.1007/s11605-014-2576-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
91 Shigematsu Y, Niwa T, Yamashita S, Taniguchi H, Kushima R, Katai H, Ito S, Tsukamoto T, Ichinose M, Ushijima T. Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers. Oncol Lett 2012;4:268-74. [PMID: 22844368 DOI: 10.3892/ol.2012.708] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
92 Kawazoe H, Shimasaki M, Ueno M, Sumikawa S, Takatori S, Namba H, Yoshida M, Sato K, Kojima Y, Watanabe Y, Moriguchi T, Tanaka A, Araki H. Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer. J Cancer 2015;6:464-9. [PMID: 25874010 DOI: 10.7150/jca.11189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
93 Ueno T, Iida M, Yoshino S, Takeda S, Kubota H, Higashida M, Oka Y, Tsuruta A, Matsumoto H, Nagano H. East Versus West: Differences in Surgical Management in Asia Compared with Europe and North America. Surg Clin North Am. 2017;97:453-466. [PMID: 28325197 DOI: 10.1016/j.suc.2016.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Thomson IG, Gotley DC, Barbour AP, Martin I, Jayasuria N, Thomas J, Smithers BM. Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes. Gastric Cancer. 2014;17:152-160. [PMID: 23474836 DOI: 10.1007/s10120-013-0240-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
95 Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing Trends in Gastric Cancer Surgery. Balkan Med J 2017;34:10-20. [PMID: 28251018 DOI: 10.4274/balkanmedj.2015.1461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
96 Lin GT, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Huang CM. Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy. J Gastrointest Surg 2020;24:540-50. [PMID: 30937713 DOI: 10.1007/s11605-019-04199-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
97 Yoon SB, Park JM, Lim CH, Kim JS, Cho YK, Lee BI, Lee IS, Kim SW, Choi MG. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc 2016;83:1176-83. [PMID: 26522370 DOI: 10.1016/j.gie.2015.10.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
98 Tóth D, Plósz J, Török M. Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol 2016;8:136-46. [PMID: 26909128 DOI: 10.4251/wjgo.v8.i2.136] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
99 Miao RL, Wu AW. Towards personalized perioperative treatment for advanced gastric cancer. World J Gastroenterol. 2014;20:11586-11594. [PMID: 25206266 DOI: 10.3748/wjg.v20.i33.11586] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
100 Tokuhara Y, Morinishi T, Matsunaga T, Ohsaki H, Kushida Y, Haba R, Hirakawa E. Claudin-1, but not claudin-4, exhibits differential expression patterns between well- to moderately-differentiated and poorly-differentiated gastric adenocarcinoma. Oncol Lett 2015;10:93-8. [PMID: 26170982 DOI: 10.3892/ol.2015.3208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
101 Kim KC, Yook JH, Eisenbraun J, Kim BS, Huber R. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. BMC Complement Altern Med 2012;12:172. [PMID: 23033982 DOI: 10.1186/1472-6882-12-172] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
102 Chen RF, Huang CM, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M. Why the Proximal Splenic Artery Approach is the Ideal Approach for Laparoscopic Suprapancreatic Lymph Node Dissection in Advanced Gastric Cancer? A Large-Scale Vascular-Anatomical-Based Study. Medicine (Baltimore) 2015;94:e832. [PMID: 25950692 DOI: 10.1097/MD.0000000000000832] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Iwamuro M, Kusumoto C, Nakagawa M, Kobayashi S, Yoshioka M, Inaba T, Toyokawa T, Hori S, Tanaka S, Matsueda K, Tanaka T, Okada H. Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type. Sci Rep 2021;11:7375. [PMID: 33795810 DOI: 10.1038/s41598-021-86893-w] [Reference Citation Analysis]
104 Huang H, Wang W, Chen Z, Jin JJ, Long ZW, Cai H, Liu XW, Zhou Y, Wang YN. Prognostic factors and survival in patients with gastric stump cancer. World J Gastroenterol. 2015;21:1865-1871. [PMID: 25684953 DOI: 10.3748/wjg.v21.i6.1865] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
105 Watanabe M, Kagawa S, Kuwada K, Hashimoto Y, Shigeyasu K, Ishida M, Sakamoto S, Ito A, Kikuchi S, Kuroda S, Kishimoto H, Tomida S, Yoshida R, Tazawa H, Urata Y, Fujiwara T. Integrated fluorescent cytology with nano-biologics in peritoneally disseminated gastric cancer. Cancer Sci 2018;109:3263-71. [PMID: 30076658 DOI: 10.1111/cas.13760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
106 Zhang J, Zou S, Luo R, Zhu Z, Wang Z, Xu H, Huang B. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis? Clin Transl Oncol. 2019;. [PMID: 30977046 DOI: 10.1007/s12094-019-02103-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
107 Zhang CD, Yamashita H, Seto Y. Gastric cancer surgery: historical background and perspective in Western countries versus Japan. Ann Trans Med. 2019;7(18):493. [PMID: 31700929 DOI: 10.21037/atm.2019.08.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
108 Lin J, Zhang W, Chen W, Huang Y, Wu R, Chen X, Shen X, Zhu G. Muscle Mass, Density, and Strength Are Necessary to Diagnose Sarcopenia in Patients With Gastric Cancer. Journal of Surgical Research 2019;241:141-8. [DOI: 10.1016/j.jss.2019.03.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
109 Liang Y, Wu L, Wang X, Ding X, Liu H, Li B, Wang B, Pan Y, Zhang R, Liu N, Liang H. Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent. Chin J Cancer Res. 2015;27:580-587. [PMID: 26752932 DOI: 10.3978/j.issn.1000-9604.2015.12.02] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
110 Xue SL, Su HF, Hu XQ, Deng X, Hu ML, Xie CY. Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer. Oncol Lett 2012;4:1309-14. [PMID: 23205128 DOI: 10.3892/ol.2012.914] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
111 Osumi H, Yoshio T, Chin K, Ogura M, Kumekawa Y, Suenaga M, Matsusaka S, Shinozaki E, Miyamoto Y, Morishige K, Ishiyama A, Hirasawa T, Tsuchida T, Yamamoto Y, Fujisaki J, Igarashi M, Mizunuma N. Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer. Gastric Cancer 2016;19:625-30. [DOI: 10.1007/s10120-015-0517-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
112 Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M, Carli F, Demartines N, Griffin SM, Lassen K. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg. 2014;101:1209-1229. [PMID: 25047143 DOI: 10.1002/bjs.9582] [Cited by in Crossref: 302] [Cited by in F6Publishing: 216] [Article Influence: 43.1] [Reference Citation Analysis]
113 Taniyama D, Taniyama K, Kuraoka K, Zaitsu J, Saito A, Nakatsuka H, Sakamoto N, Sentani K, Oue N, Yasui W. Long-term follow-up study of gastric adenoma; tumor-associated macrophages are associated to carcinoma development in gastric adenoma. Gastric Cancer 2017;20:929-39. [PMID: 28321517 DOI: 10.1007/s10120-017-0713-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
114 Hayashi M, Yoshikawa T, Yura M, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T. Predictive value of the surgical Apgar score on postoperative complications in advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by radical gastrectomy: a single-center retrospective study. BMC Surg 2020;20:150. [PMID: 32652977 DOI: 10.1186/s12893-020-00813-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
115 Takahashi R, Nunobe S, Osumi H, Takahari D, Yamamoto N, Ida S, Kumagai K, Ohashi M, Sano T, Hiki N. Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer. Surg Today 2020;50:1240-8. [PMID: 32451714 DOI: 10.1007/s00595-020-02011-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Ma FH, Liu H, Ma S, Li Y, Tian YT. Current controversies in treating remnant gastric cancer: Are minimally invasive approaches feasible? World J Clin Cases 2019;7:3384-93. [PMID: 31750323 DOI: 10.12998/wjcc.v7.i21.3384] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Young E, Philpott H, Singh R. Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. WJG 2021;27:5126-51. [DOI: 10.3748/wjg.v27.i31.5126] [Reference Citation Analysis]
118 Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: A review. World J Gastrointest Oncol 2018;10:398-409. [PMID: 30487951 DOI: 10.4251/wjgo.v10.i11.398] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
119 Wang W, Chen Z, Jin J, Long Z, Liu X, Cai H, Zhou Y, Huang H, Wang Y. MDM2 binding protein as a predictor of metastasis and a novel prognostic biomarker in patients with gastric cancer. Oncol Lett 2017;14:6409-16. [PMID: 29422956 DOI: 10.3892/ol.2017.7031] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
120 Einama T, Abe H, Shichi S, Matsui H, Kanazawa R, Shibuya K, Suzuki T, Matsuzawa F, Hashimoto T, Kohei N, Homma S, Kawamura H, Taketomi A. Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer. Mol Clin Oncol 2017;6:163-6. [PMID: 28357085 DOI: 10.3892/mco.2017.1128] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
121 Aoyagi K, Kouhuji K, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting to treat gastric cancer. World J Gastroenterol. 2014;20:13741-13755. [PMID: 25320512 DOI: 10.3748/wjg.v20.i38.13741] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
122 Park YK, Yoon HM, Kim YW, Park JY, Ryu KW, Lee YJ, Jeong O, Yoon KY, Lee JH, Lee SE, Yu W, Jeong SH, Kim T, Kim S, Nam BH; COACT group. Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: Results From a Randomized Phase II Multicenter Clinical Trial (COACT 1001). Ann Surg. 2018;267:638-645. [PMID: 28187041 DOI: 10.1097/sla.0000000000002168] [Cited by in Crossref: 81] [Cited by in F6Publishing: 36] [Article Influence: 40.5] [Reference Citation Analysis]
123 Han G, Park JY, Kim YJ. Comparison of short-term postoperative outcomes in totally laparoscopic distal gastrectomy versus laparoscopy-assisted distal gastrectomy. J Gastric Cancer. 2014;14:105-110. [PMID: 25061537 DOI: 10.5230/jgc.2014.14.2.105] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
124 Oguri Y, Okui M, Yamamichi T, Asakawa A, Harada M, Horio H. The impact of pulmonary metastasectomy from gastric cancer. Mol Clin Oncol 2019;11:401-4. [PMID: 31497298 DOI: 10.3892/mco.2019.1910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Ishibashi F, Fukushima K, Ito T, Kobayashi K, Tanaka R, Onizuka R. Influence of Helicobacter pylori Infection on Endoscopic Findings of Gastric Adenocarcinoma of the Fundic Gland Type. J Gastric Cancer 2019;19:225-33. [PMID: 31245167 DOI: 10.5230/jgc.2019.19.e21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Tokunaga M, Sugisawa N, Kondo J, Tanizawa Y, Bando E, Kawamura T, Terashima M. Early phase II study of robot-assisted distal gastrectomy with nodal dissection for clinical stage IA gastric cancer. Gastric Cancer. 2014;17:542-547. [PMID: 24005955 DOI: 10.1007/s10120-013-0293-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
127 Guo TJ, Qin JY, Zhu LL, Wang J, Yang JL, Wang YP. Feasible endoscopic therapy for early gastric cancer. World J Gastroenterol 2015;21:13325-31. [PMID: 26715816 DOI: 10.3748/wjg.v21.i47.13325] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
128 Ma FH, Xue LY, Chen YT, Li WK, Li Y, Kang WZ, Xie YB, Zhong YX, Xu Q, Tian YT. Surgical resection of gastric stump cancer following proximal gastrectomy for adenocarcinoma of the esophagogastric junction. World J Gastrointest Oncol. 2019;11:416-423. [PMID: 31139311 DOI: 10.4251/wjgo.v11.i5.416] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Son T, Hyung WJ. Laparoscopic gastric cancer surgery: Current evidence and future perspectives. World J Gastroenterol. 2016;22:727-735. [PMID: 26811620 DOI: 10.3748/wjg.v22.i2.727] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
130 Dong YP, Deng JY. Advances in para-aortic nodal dissection in gastric cancer surgery: A review of research progress over the last decade. World J Clin Cases 2020;8:2703-16. [PMID: 32742981 DOI: 10.12998/wjcc.v8.i13.2703] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kim CH, Song KY, Park CH, Seo YJ, Park SM, Kim JJ. A comparison of outcomes of three reconstruction methods after laparoscopic distal gastrectomy. J Gastric Cancer. 2015;15:46-52. [PMID: 25861522 DOI: 10.5230/jgc.2015.15.1.46] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
132 d'Avella E, Guadagno E, Ugga L, Solari D, Cavallo LM. Anterior Clinoid Metastasis as First Presentation of a Signet Ring Cell Carcinoma: An Intriguing Diagnosis. J Neurol Surg Rep 2020;81:e46-51. [PMID: 32818133 DOI: 10.1055/s-0040-1712919] [Reference Citation Analysis]
133 Min SH, Lee CM, Jung HJ, Lee KG, Suh YS, Shin CI, Kim HH, Yang HK. Laparoscopic distal gastrectomy in a patient with situs inversus totalis: a case report. J Gastric Cancer 2013;13:266-72. [PMID: 24511424 DOI: 10.5230/jgc.2013.13.4.266] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
134 Noshiro H, Ikeda O, Urata M. Robotically-enhanced surgical anatomy enables surgeons to perform distal gastrectomy for gastric cancer using electric cautery devices alone. Surg Endosc. 2014;28:1180-1187. [PMID: 24202713 DOI: 10.1007/s00464-013-3304-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
135 Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer 2016;19:329-38. [PMID: 26643880 DOI: 10.1007/s10120-015-0575-z] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 19.0] [Reference Citation Analysis]
136 Ueda Y, Shiroshita H, Etoh T, Inomata M, Shiraishi N. Laparoscopic proximal gastrectomy for early gastric cancer. Surg Today. 2017;47:538-547. [PMID: 27549773 DOI: 10.1007/s00595-016-1401-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
137 Kuwata T, Yanagihara K, Iino Y, Komatsu T, Ochiai A, Sekine S, Taniguchi H, Katai H, Kinoshita T, Ohtsu A. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts. Cells 2019;8:E585. [PMID: 31207870 DOI: 10.3390/cells8060585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
138 Nie RC, Yuan SQ, Li YF, Chen YM, Chen XJ, Zhu BY, Xu LP, Zhou ZW, Chen S, Chen YB. Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis. J Cancer 2017;8:3396-404. [PMID: 29151922 DOI: 10.7150/jca.21017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
139 Galizia G, Lieto E, De Vita F, Castellano P, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, De Sena G, De Stefano L. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery. 2015;157:285-296. [PMID: 25532433 DOI: 10.1016/j.surg.2014.09.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
140 Moehler M, Baltin CTH, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer H, Palmqvist A, Röcken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wittekind C, Wagner D, Mönig SP. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer 2015;18:550-63. [DOI: 10.1007/s10120-014-0403-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
141 Kodera Y, Kobayashi D, Tanaka C, Fujiwara M. Gastric adenocarcinoma with para-aortic lymph node metastasis: A borderline resectable cancer? Surg Today. 2015;45:1082-1090. [PMID: 25366353 DOI: 10.1007/s00595-014-1067-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
142 Uyama I, Suda K, Satoh S. Laparoscopic surgery for advanced gastric cancer: current status and future perspectives. J Gastric Cancer. 2013;13:19-25. [PMID: 23610715 DOI: 10.5230/jgc.2013.13.1.19] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
143 Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, Kosaka T, Akiyama H, Endo I, Misumi T. Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival? Ann Surg Oncol 2019;26:4452-63. [PMID: 31529308 DOI: 10.1245/s10434-019-07790-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
144 Yu JI, Lim DH, Ahn YC, Lee J, Kang WK, Park SH, Park JO, Park YS, Lim HY, Kim ST, Kim S, Sohn TS, Choi MG, Bae JM, Nam H. Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial. Radiother Oncol 2015;117:171-7. [PMID: 26299196 DOI: 10.1016/j.radonc.2015.08.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
145 Xu K, Shi M, Zhang W, Shi Y, Dong Q, Shen X, Chen X, Lin J. Preoperative Fibrosis-4 (FIB-4) Evaluation May Be Helpful to Evaluate Prognosis of Gastric Cancer Patients Undergoing Operation: A Retrospective Study. Front Oncol 2021;11:655343. [PMID: 34221972 DOI: 10.3389/fonc.2021.655343] [Reference Citation Analysis]
146 Tuttle R, Hochwald SN, Kukar M, Ben-david K. Total laparoscopic resection for advanced gastric cancer is safe and feasible in the Western population. Surg Endosc 2016;30:3552-8. [DOI: 10.1007/s00464-015-4652-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
147 Zheng Z, Zhang Y, Zhang L, Li Z, Wu A, Wu X, Liu Y, Bu Z, Ji J. Nomogram for predicting lymph node metastasis rate of submucosal gastric cancer by analyzing clinicopathological characteristics associated with lymph node metastasis. Chin J Cancer Res 2015;27:572-9. [PMID: 26752931 DOI: 10.3978/j.issn.1000-9604.2015.12.06] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
148 Yamaguchi K, Yoshida K, Tanahashi T, Takahashi T, Matsuhashi N, Tanaka Y, Tanabe K, Ohdan H. The long-term survival of stage IV gastric cancer patients with conversion therapy. Gastric Cancer 2018;21:315-23. [PMID: 28616743 DOI: 10.1007/s10120-017-0738-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
149 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
150 Mönig SP, Chon SH, Weindelmayer J, de Manzoni G, Hölscher AH. [Spectrum of laparoscopic surgery for gastric tumors]. Chirurg 2014;85:675-82. [PMID: 25052815 DOI: 10.1007/s00104-014-2753-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
151 Baba H, Kuwabara K, Ishiguro T, Kumamoto K, Kumagai Y, Ishibashi K, Haga N, Ishida H. Prognostic factors for stage IV gastric cancer. Int Surg 2013;98:181-7. [PMID: 23701157 DOI: 10.9738/INTSURG-D-12-00027.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
152 Yamamoto M, Kurokawa Y, Miyazaki Y, Makino T, Takahashi T, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence. World J Surg. 2016;40:1904-1909. [PMID: 26969673 DOI: 10.1007/s00268-016-3474-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
153 Nakamura N, Kinami S, Tomita Y, Miyata T, Fujita H, Takamura H, Ueda N, Kosaka T. The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study. BMC Cancer 2020;20:363. [PMID: 32349701 DOI: 10.1186/s12885-020-06884-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]